<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN"
       "https://jats.nlm.nih.gov/publishing/1.3/JATS-journalpublishing1-3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" dtd-version="1.3" article-type="research-article" xml:lang="en">
 <front>
  <journal-meta>
   <journal-id journal-id-type="nlm-ta">Ulutas Med J</journal-id>
   <journal-title-group>
    <journal-title>The Ulutas Medical Journal</journal-title>
    <abbrev-journal-title>Ulutas Med J</abbrev-journal-title>
   </journal-title-group>
   <issn pub-type="ppub">2149-0430</issn>
   <issn pub-type="epub">2149-388X</issn>
   <publisher>
    <publisher-name>Hayriye Zehra Ulutaş</publisher-name>
   </publisher>
  </journal-meta>
  <article-meta>
   <article-id pub-id-type="doi">10.5455/umj.20210617094444</article-id>
   <article-id pub-id-type="publisher-id">88876</article-id>
   <article-categories>
    <subj-group subj-group-type="heading">
     <subject>Original Article</subject>
    </subj-group>
    <subj-group subj-group-type="subject">
     <subject>Gastroenterology</subject>
    </subj-group>
   </article-categories>
   <title-group>
    <article-title>A Comparative Study Investigating the Necessity of Prophylactic Systemic Antibiotic and Gentamicin Tunnel Lavage' in Peroral Endoscopic Myotomy (Poem) and Similar Tunneling Procedures (Z-D-G Poem)</article-title>
   </title-group>
   <contrib-group>
    <contrib contrib-type="author" corresp="yes">
     <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-8209-1513</contrib-id>
     <name name-style="western">
      <surname>Akar</surname>
      <given-names>Tarik</given-names>
     </name>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing – original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing – original draft</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing – review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
     <xref ref-type="aff" rid="aff1">1</xref>
    </contrib>
    <aff id="aff1">
     <label>1</label>
     <institution-wrap>
      <institution-id institution-id-type="ror">https://ror.org/00pkvys92</institution-id>
      <institution>Department of Gastroenterology, Istanbul Hisar Intercontinental Hospital, Istanbul, Turkey</institution>
     </institution-wrap>
    </aff>
   </contrib-group>
   <pub-date publication-format="electronic" date-type="pub" iso-8601-date="2021-09-26">
    <day>26</day>
    <month>09</month>
    <year>2021</year>
   </pub-date>
   <pub-date publication-format="print" date-type="collection">
    <year>2021</year>
   </pub-date>
   <volume>7</volume>
   <issue>3</issue>
   <fpage>193</fpage>
   <lpage>202</lpage>
   <history>
    <date date-type="received" iso-8601-date="2021-06-23">
     <day>23</day>
     <month>06</month>
     <year>2021</year>
    </date>
    <date date-type="rev-recd" iso-8601-date="2021-07-08">
     <day>08</day>
     <month>07</month>
     <year>2021</year>
    </date>
    <date date-type="accepted" iso-8601-date="2021-07-25">
     <day>25</day>
     <month>07</month>
     <year>2021</year>
    </date>
   </history>
   <permissions>
    <copyright-statement>© 2021 The Author(s)</copyright-statement>
    <copyright-year>2021</copyright-year>
    <license>
     <ali:license_ref>https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref>
     <license-p>This is an open access article distributed under the CC BY-NC 4.0 licence.</license-p>
    </license>
   </permissions>
   <self-uri xlink:href="https://www.ulutasmedicaljournal.com/?mno=88876"/>
   <self-uri content-type="pdf" xlink:href="https://www.ulutasmedicaljournal.com/pdf/88876.pdf"/>
   <abstract>
    <p>Introduction: Peroral endoscopic myotomy (POEM) and similar procedures (Z-D-G POEM) are one of the most remarkable topics recently in the gastroenterology community. In this paper, we aimed to investigate the necessity of prophylactic 'systemic antibiotic and gentamicin tunnel lavage' in these procedures. Materials and Methods: From August 2018 to May 2021, we performed Achalasia POEM (35), Zenker's POEM (3), Diverticulum POEM (1), and Gastric POEM (2). Of these, 21 patients received prophylactic systemic antibiotic and gentamicin tunnel lavage' and the others (20 patients) nothing. The primary topics of the research were an adverse event, fever, changes in inflammatory markers(c-reactive protein (CRP), white blood cell(WBC), the length of hospital stay, and re-admission rate to the hospital. Results: The mean age was 46.96±15.44 (21-78) and male/female ratio was 26 (67.9%) /15 (32.1%). Comparing groups with and without antibiotics, there was no difference between the two groups as to several adverse events, hospital stay, fever, levels of CRP, and WBC count(all p-values&gt;0.05). The median CRP values on day 1 and day 3 were somewhat high in the antibiotic negative group but were not statistically different (p:0.667 and p:0.839). The median values of WBC of days 1, 3, and 5 were similar in both groups (all p-values&gt;0.05). The mean follow-up days were 396±182.7 and 197.7±18.62 in the antibiotic (+) and antibiotic (-) groups, respectively (p&lt;0.05). Despite such a long follow-up, no patient has been re-administered to the hospital due to infection-related complications. Conclusion: In this paper, we have shown that the application of prophylactic systemic antibiotic and gentamicin tunnel lavage' may not be required in POEM and similar procedures.</p>
   </abstract>
   <kwd-group kwd-group-type="author">
    <kwd>Peroral endoscopic myotomy</kwd>
    <kwd>antibiotic</kwd>
    <kwd>gentamicin</kwd>
    <kwd>achalasia</kwd>
    <kwd>dysphagia</kwd>
    <kwd>infection</kwd>
   </kwd-group>
   <funding-group>
    <funding-statement>Funding information was not reported in the published version of this article.</funding-statement>
   </funding-group>
  </article-meta>
 </front>
 <body>
  <sec id="sec-1">
   <title>Introduction</title>
   <p id="b-1">Achalasia is a chronic progressive disease that mainly causes difficulty swallowing both liquid and solid. With the remarkable developments in its diagnosis and treatment, this disease has been the subject of many important studies and articles in recent years (    <xref ref-type="bibr" rid="ref1">1</xref>
). Early traditional treatmentoption for the disease was pneumatic dilatation, botox injection, and Laparoscopic Heller myotomy (LHM) in the past two or three decades, but the success rate was not at the desirable level, especially in patients with type 2 and 3 achalasia (    <xref ref-type="bibr" rid="ref1">1</xref>
,    <xref ref-type="bibr" rid="ref2">2</xref>
). Because of unmet needs, in 2010, Prof.Inoue launched the first case of tunneling procedure which is to be called as “Peroral endoscopic myotomy (POEM)” in a young achalasia patient (    <xref ref-type="bibr" rid="ref1">1</xref>
). POEM is a new minimally invasive and innovative treatment that is basically developed for achalasia a nd subsequently used for the treatment of Zenker's diverticulum (Z-POEM), Epiphrenic diverticulum (D-POEM), and Gastroparesis-gastric-(G-POEM) (    <xref ref-type="bibr" rid="ref3">3</xref>
,    <xref ref-type="bibr" rid="ref4">4</xref>
). The main advantages of POEM and similar procedures to traditional surgical treatments are the absence of any skin scars on the body surface, short processing time, chance of long-length myotomy, fast and easy post-operative recovery as well as low complication rates (    <xref ref-type="bibr" rid="ref5">5</xref>
). And now, POEM is accepted as one of the most popular and advanced endoscopic procedures in the world. POEM is like a surgical procedure, performed under general anesthesia without rigor surgical principles. As expected, it can be done after a learning period with a master's doctor. Initially, many endoscopists learned this procedure from Prof. Inoue. The ‘gentamicin tunnel lavaging’ was the routine procedure of Prof. Inoue’s description during POEM, he called it as a ‘Holy water’, and he always said ‘there was no evidence for that application’. Also, there was no evidence about assessing the necessity of this application in the literature (    <xref ref-type="bibr" rid="ref6">6</xref>
). Initially, gentamicin tunnel lavage was probably used mainly to prevent serious and fatal infective complications such as mediastinitis, empyema, and abscess (    <xref ref-type="bibr" rid="ref1">1</xref>
,    <xref ref-type="bibr" rid="ref2">2</xref>
). During the rapid spread of POEM to the world, the application of ‘gentamicin tunnel lavage’ was done by many POEM performer doctors without questioning its necessity. Following years, some centers added ‘systemic antibiotic using’ to gentamicin tunnel lavage. Consequently, dual application (systemic antibiotic and gentamicin tunnel lavaging) was perceived as a routine procedure in POEM without question of need (    <xref ref-type="bibr" rid="ref7">7</xref>
,    <xref ref-type="bibr" rid="ref8">8</xref>
). However, we do still not know what kind of clinical practice (systemic prophylactic antibiotic with/without gentamicin tunnel lavage) and which antibiotics are performing by all POEM operators during POEM procedure.</p>
   <p id="b-2">The first human case of POEM was almost made 11years ago and subsequently completed nearly more than 20000 successful procedures all over the world, but only two guidelines for POEM procedure were published (    <xref ref-type="bibr" rid="ref9">9</xref>
,    <xref ref-type="bibr" rid="ref10">10</xref>
). In the first guide published in 2018 prepared by Inoue, many detailed issues (detailed procedure descriptions, indications, contraindications, side effects, management of complications and postoperative follow-up) have been addressed, but there is no clear recommendation for ‘prophylactic systemic antibiotic using’ and ‘gentamicin lavaging into the tunnel’(    <xref ref-type="bibr" rid="ref9">9</xref>
). European Society of Gastrointestinal Endoscopy (ESGE) guideline recommends a single dose of prophylactic antibiotic injection intravenously before inductionof anesthesia when performing POEM, but reference articles given in this manual are very old (from the 1980s and 1990s), and most are them not full-text.Therefore, ESGE recommendations include low-quality evidence (    <xref ref-type="bibr" rid="ref10">10</xref>
). This topic is still hot and very controversial for centers performing advanced endoscopic procedures.</p>
   <p id="b-3">In almost all major articles (with a large patient number) published so far, systemic antibiotics and gentamicin tunnel lavaging have been used (    <xref ref-type="bibr" rid="ref5">5</xref>
,    <xref ref-type="bibr" rid="ref7">7</xref>
,    <xref ref-type="bibr" rid="ref11">11</xref>
–    <xref ref-type="bibr" rid="ref14">14</xref>
). When examined these articles carefully, none of them gives details about why systemic antibiotics and gentamicin tunnel lavaging are used (    <xref ref-type="bibr" rid="ref3">3</xref>
,    <xref ref-type="bibr" rid="ref11">11</xref>
,    <xref ref-type="bibr" rid="ref15">15</xref>
,    <xref ref-type="bibr" rid="ref16">16</xref>
). There are very few articles on this subject, and one of them, Bayer et al., have shown that gentamicin tunnel lavage has no benefit in preventing infection (    <xref ref-type="bibr" rid="ref17">17</xref>
). The risk of dangerous infection should be expected to be low with the development of the POEM technique in time and more frequent application by expert (    <xref ref-type="bibr" rid="ref2">2</xref>
,    <xref ref-type="bibr" rid="ref5">5</xref>
,    <xref ref-type="bibr" rid="ref12">12</xref>
). Considering the dangerous changes of unnecessary antibiotics using on microbiota in recent years and the possible harmful effects to other organs, it has become very important for us to question the use of antibiotics in the POEM process (    <xref ref-type="bibr" rid="ref18">18</xref>
). We need to talk about that traditional habits should be investigated and revised if there is no evidence about them. In this paper, we investigated the necessity of prophylactic systemic antibiotic using and tunnel lavaging with gentamycin in our case series. with a retrospective manner.</p>
  </sec>
  <sec id="sec-2">
   <title>Materials and Methods</title>
  </sec>
  <sec id="sec-3">
   <title>Study Design</title>
   <p id="b-4">We retrospectively analyzed our patient's data which were performed between August 2018 and June 2021. All procedures were tunneling process. The case series consisted of 35 Achalasia POEM, 3 Zenker’s POEM, 1 Epiphirenic Diverticulum POEM, and 2 Gastric POEM. All patients had a prominent symptom and a clear indication for special procedures to be performed. A high-resolution manometry for the achalasia patients, contrast swallow esophagram for diverticulum disease (Zenker’s and Epiphirenic Diverticulum), and a study of gastric emptying time for gastroparesis was performed before the procedure. Except for one patient (Heller myotomy), no treatment attempts before (pneumatic balloon dilatation, injection of botulinum toxin, laparoscopic) had been made. We started tunneling procedures in August 2018, as everyone does, we used systemic antibiotics (ampicillin/sulbactam or ceftriaxone) and tunnel lavaging with gentamicin in all initial POEM procedures. Nearly after completed the 21    <sup>st </sup>
procedure, we abandoned both ‘systemic antibiotic using’ and ‘gentamicin tunnel lavaging’, and continued others procedures in this way. Most of the first 14 cases (66 %) were done with the help of a more experienced doctor on POEM. Z-D and G-POEM procedures were performed after the 15    <sup>th</sup>
 Achalasia POEM procedure. The POEM procedure was done traditionally as clearly explained in many previous articles. Antibiotic using and tunnel lavaging with gentamycin were made as follows; ampicillin/sulbactam (intravenous)(2    <sub>x</sub>
1gr) or ceftriaxone (intravenous) (2x1gr) was started one day of POEM procedure and continued postoperative five days. The gentamicin tunnel lavaging (2 vials 40 mg gentamicin with 100 cc saline) was applied by administering a spray catheter after myotomy is finished. Almost all procedures were scheduled on Thursday of a week and planned to be discharged the following Monday (5 days for a hospital stay). The primary topics of the research were to investigate adverse event rate, fever pattern, the changes of inflammatory markers [(c-reactive protein (CRP), white blood cell count (WBC)], the length of hospital stay (after operation), and infection-related admission to the hospital during long-term follow-up. The normal range of CRP levels was between 0-5 mg/dl and WBC was 4-10x10    <sup>9</sup>
/L. Fever was accepted if above 37.5    <sup>0 </sup>
Celcius.</p>
   <sec id="sec-4">
    <title>Radiological Assessment</title>
    <p id="b-5">A Computed tomography (thorax or abdomen) was performed on all patients on the day after the procedure due to investigate the esophageal leak and minor complications. All patients were followed up at least 3 months for complications related to infection and others.</p>
   </sec>
  </sec>
  <sec id="sec-5">
   <title>Ethical Statement</title>
   <p id="b-6">Local ethic committe of Bülent Ecevit University approved the study (29/04/2019    <sub> - </sub>
2020/09). The study was carried out following the Declaration of Helsinki. Data analysis was carried out with the SPSS version 18 (Chicago, IL, USA). First, the distribution of variables was examined by Shapiro-Wilk and Kolmogorov-Smirnow tests, and the necessary statistical analysis was determined. Normally distributed and non-distributed variables were expressed as they should be. Mann-Whitney-U and independent t-test were used for the difference between the independent variables depending on whether variables are normally distributed or not. P value&lt;0.05 was considered significant.</p>
  </sec>
  <sec id="sec-6">
   <title>Results</title>
   <p id="b-7">A total of 41 patients were included in the study. 35 of them were achalasia POEM, 3 were Zenker’s POEM, 1 was Diverticulum POEM and 2 was Gastric POEM. Briefly, the mean age was 46.96±15.44 (21-78) and male/female (ratio) was 26(67.9%)/15(32.1%). The success rate was 97.5%, and one POEM (achalasia) was not completed due to a ventilation problem created by probably over carbon dioxide insufflation during the middle of the procedure. While the median operation time was 102 minutes, the longest operation time was 253 minutes. These 41 patients were divided into two groups according to the condition of antibiotic use status; antibiotic (ATB-group) and non-antibiotic (NATB group). The group of ATB (consisted of 21 patients) identifies taking systemic antibiotic [(ampicillin-sulbactam; 9 (42.9%), ceftriaxone: 12 (57.1%)] and gentamicin tunnel lavage. The group of NATB (consisted of 20 patients) specifies patients who have not taken any systemic antibiotics and gentamicin tunnel lavage. A piece of compact information showing the basic descriptive characteristics of the study patients is summarized in Table-1. The two groups (ATB=21 and NATB=20) were similar in basic data such as mean age, gender, and co-morbid disease. The median procedure time of ATP group [117.5 (85-240)] was longer than [67.5 (32-253)] NATP group (p&lt;0.05). The longest procedure time was 253 minutes in the NATB group. Detailed information about the groups is given in Table 2. The main objective of the study was to compare those groups in terms of inflammatory markers change, fever, stay of the hospital, and any infection-related complications at the time of post-operative period and long-term follow-up. There was no difference between the two groups as to adverse events, fever, c-reactive protein, and white blood cell count (all p-values&gt;0.05). CRP and WBC values selected as inflammatory markers were examined on the operation day, day 3, and day 5. The median CRP values on day 1 and day 3 were somewhat high in the NATB but were not significantly different (p:0.667 and p:0.839).The mean CRP (operation day, day 1, day 3, day 5) was similar both groups (33.73±14.9 vs 37.2±24.6)(p:0.652)(Figure-1/2). The median (operation day, days 1,3, and 5) and mean white blood cell counts were similar in both two groups (all p-values &gt;0.05). A total of 15 adverse events were revealed in this period, all of them mild and none of them required a further surgical or interventional operation (Table-2). The number of adverse events was similar in both two groups (9 vs. 6, p:0.532). The mean follow-up was 396±186.7 and 197.7±18.6 in ATP and NATP, respectively (p&lt;0.05)(Table- 2). Despite such a long follow-up(almost 1 year), no patient has been re-administered to the hospital due to infection-related complications.</p>
   <table-wrap id="tbl-1" position="float">
    <label>Table 1</label>
    <caption>
     <title>Basic descriptive information of the study cohort</title>
    </caption>
    <graphic xlink:href="tbl-1.png">
     <alt-text>Table 1: Basic descriptive information of the study cohort</alt-text>
    </graphic>
   </table-wrap>
   <table-wrap id="tbl-2" position="float">
    <label>Table 2</label>
    <caption>
     <title>Comparison of two groups of patients who took antibiotic or not in terms of basic demographic data, inflammatory markers, fever, side effects and duration of hospitalization</title>
    </caption>
    <graphic xlink:href="tbl-2.png">
     <alt-text>Table 2: Comparison of two groups of patients who took antibiotic or not in terms of basic demographic data, inflammatory markers, fever, side effects and duration of hospitalization</alt-text>
    </graphic>
   </table-wrap>
   <fig id="fig-1" position="float">
    <label>Figure 1</label>
    <caption>
     <p>There is no difference between the antibiotic positive and negative groups in terms of mean and median CRP values</p>
    </caption>
    <graphic xlink:href="fig-1.png">
     <alt-text>Figure 1: There is no difference between the antibiotic positive and negative groups in terms of mean and median CRP values</alt-text>
    </graphic>
   </fig>
   <fig id="fig-2" position="float">
    <label>Figure 2</label>
    <caption>
     <p>There is no difference between the antibiotic positive and negative groups in terms of mean and median white blood cell count</p>
    </caption>
    <graphic xlink:href="fig-2.png">
     <alt-text>Figure 2: There is no difference between the antibiotic positive and negative groups in terms of mean and median white blood cell count</alt-text>
    </graphic>
   </fig>
  </sec>
  <sec id="sec-7">
   <title>Discussion</title>
   <p id="b-8">While there are many articles in the literature regarding the POEM technique, most ofthem are related to technique, complications, and efficacy, there is little information about the way and duration of antibiotic use in the POEM procedure. This is the first article to investigate the necessity of the use of both prophylactic systemic and in-tunnel antibiotics in POEM procedures and afterward.</p>
   <p id="b-9">Achalasia is a rare, slowly progressive neuro-degenerative disease characterized by difficulty swallowing. Considering the medical history of this disease in the last 15 years, remarkable progress is observed in both diagnosis and treatment (    <xref ref-type="bibr" rid="ref1">1</xref>
). In recent years, it has attracted great interest in the medical community, as a shining star, among other gastrointestinal diseases due to the success of a new minimally invasive therapy developed recently. The name of this endoscopic minimally invasive treatment is POEM. The POEM, which is the first 3    <sup>rd</sup>
 space endoscopy technique, has been developed primarily for Achalasia treatment in 2010 and subsequently used for Zenker’s and Epiphrenic Diverticulum, Gastroparesis (Z-D-G POEM) as well as Sub-epithelial tumor resection (STER) (    <xref ref-type="bibr" rid="ref6">6</xref>
,    <xref ref-type="bibr" rid="ref19">19</xref>
). They are called “digestive endoscopic tunnel techniques” and are the most important innovative and groundbreaking developments in gastroenterology within the last decades (    <xref ref-type="bibr" rid="ref6">6</xref>
). Considering the technical details of the POEM process; unlike LHM, myotomy is performed in the mediastinal region by a ‘non-sterile endoscope’ passing through the mouth that contains many bacteria and fungi (    <xref ref-type="bibr" rid="ref20">20</xref>
). In some POEM procedures, it is necessary to interrupt and re-enter with an endoscope due to over insufflation of carbon dioxide or cleaning of the endoscopic lens. Every entry and exit with a non-sterile endoscope creates a fear that it may cause bacteria to be transported from the mouth flora to the sterile operation site (    <xref ref-type="bibr" rid="ref21">21</xref>
). On the other hand, the second factor, perhaps a more important risk than the first, is problems related to post-operative esophageal leakage whether from the mucosal entrance site due to clip dislocation or ischemia/ damage of esophageal mucosa (    <xref ref-type="bibr" rid="ref22">22</xref>
). It is very important to notice at the early stage to keep the patient safe. The leakage usually occurs within the first postoperative following 3 days and it is very important to monitor the patient’s clinic, fever, c-reactive protein, and white blood cells for early recognition (    <xref ref-type="bibr" rid="ref5">5</xref>
,    <xref ref-type="bibr" rid="ref22">22</xref>
).</p>
   <p id="b-10">The possibility of severe adverse events of POEM and similar procedures is very rare compared to surgery (    <xref ref-type="bibr" rid="ref11">11</xref>
,    <xref ref-type="bibr" rid="ref23">23</xref>
). Many adverse events are mild to moderate and occur within the first 48 hours and are commonly managed with no further intervention (    <xref ref-type="bibr" rid="ref14">14</xref>
). However, many endoscopists have a serious fear that infective complications are very rare but can be fatal and early recognition infection remains essential (    <xref ref-type="bibr" rid="ref22">22</xref>
). Many centers and endoscopists use systemic antibiotics and gentamicin tunnel lavage during POEM and similar tunnel procedures. Most center use systemic antibiotic differently; some centers use only a single perioperative intravenous antibiotic, while other centers use systemic antibiotic both perioperative and post-operative 5 days (    <xref ref-type="bibr" rid="ref7">7</xref>
,    <xref ref-type="bibr" rid="ref8">8</xref>
). However, there is still insufficient and very weak evidence for the necessity of this (    <xref ref-type="bibr" rid="ref9">9</xref>
,    <xref ref-type="bibr" rid="ref14">14</xref>
). Also, we still do not know what kind of antibiotics (how long and in which way) are using by POEM operators during achalasia treatment. In summary, there is serious debate and complete confusion about “the use of systemic antibiotics and gentamicin tunnel lavage” in POEM and similar tunnel procedures due to the lack of enough evidence (    <xref ref-type="bibr" rid="ref17">17</xref>
,    <xref ref-type="bibr" rid="ref19">19</xref>
).</p>
   <p id="b-11">The POEM and similar procedures increase day by day all over the world but there are only a few well-written, clear and detailed guidelines about it (    <xref ref-type="bibr" rid="ref9">9</xref>
). The most important deficiency of guidelines is the lack of sufficient data on antibiotic use. There are only two guidelines on this subject and there is no recommendation due to insufficient evidence on this subject (    <xref ref-type="bibr" rid="ref9">9</xref>
,    <xref ref-type="bibr" rid="ref10">10</xref>
,    <xref ref-type="bibr" rid="ref24">24</xref>
,    <xref ref-type="bibr" rid="ref25">25</xref>
). In the ESGE guideline, the studies cited in this guide are small samples and not full-text. In a prospective randomized controlled trial by Zhai in 52 POEM patients, it was reported that giving 2 gr of intravenous ceftriaxone sodium preoperatively did not provide any additional clinical benefit in the prevention of infection (    <xref ref-type="bibr" rid="ref26">26</xref>
). The second guideline representing Japanese experience, there is no statement regarding the use of antibiotics (    <xref ref-type="bibr" rid="ref9">9</xref>
). Briefly, unfortunately, two guidelines do not show a clear direction to endoscopists regarding the use of antibiotics in POEM and similar procedures.</p>
   <p id="b-12">In this study, we conducted a retrospective study to provide evidence for this controversial issue. The main purpose of this article is to question whether prophylactic antibiotic use is required in these procedures. A total of 28 patients were included. Of these, while 14 patients received systemic antibiotics (5 days) and gentamicin tunnel lavage, the other 14 patients did not take any antibiotics. These two were compared in terms of inflammatory markers (CRP, WBC), length of hospital stay, fever, and adverse event, and no difference was detected (all p&gt;0.05). Unlike other studies, the inflammatory marker levels of the post-operative first 5 days were examined in detail. In terms of CRP, the median CRP levels were slightly low in postoperative days 1 and 3 in patients receiving antibiotics, but it was statistically insignificant (Figure 1).</p>
   <p id="b-13">Potential infection-related complications in POEM and similar procedures are still very rare (    <xref ref-type="bibr" rid="ref21">21</xref>
). Possible scenarios can be evaluated as aspiration pneumonia, empyema, and mediastinitis(    <xref ref-type="bibr" rid="ref14">14</xref>
). In POE and similar procedures, potential bacterial contamination with a non-sterile endoscope is possible after full-thickness myotomy in the mediastinum and peritoneal cavity. However, there is no clear evidence as to whether this plays a role in infection (    <xref ref-type="bibr" rid="ref21">21</xref>
). Unlike other advanced endoscopic way, maintaining the integrity of the mucosa is the most important issue for preventing complications. Mucosal integrity can be impaired in two ways; the first is ‘reopening’ the mucosal entrance due to clip dislocation, the second is ‘delayed mucosal perforation’ due to excessive thermal effect of cautery (    <xref ref-type="bibr" rid="ref21">21</xref>
). These two main factors that can lead to infection complications are completely related to the experience of the operator performing the POEM procedure. In the research paper published in 2016 by Zang et al, which is included a retrospective analysis of single-center with 1680 patients information about major adverse event rate in 5 years analysis, the adverse event rate was 3.3% and most of them were delayed mucosal barrier insufficiency and pneumothorax, but none of them required surgery (    <xref ref-type="bibr" rid="ref27">27</xref>
). In a large and multicenter international study consisted of a well-covered retrospective analysis of 1826 patients written by Haito-Chavez, the adverse event rate was 7.5%, but the severe adverse event rate was (0.5%) (    <xref ref-type="bibr" rid="ref14">14</xref>
). The most common of these were inadvertent mucosotomy (2.8%), symptomatic capnoperitoneum (1.2%), and esophageal leak (0.7%). Mild, moderate, and severe adverse event rate was 6.4% (116), 1.7% (31), and 0.5% (    <xref ref-type="bibr" rid="ref9">9</xref>
) respectively. The most adverse event was managed conservatively and endoscopically, but only 2.6% required further surgery, and 19.9% required percutaneous drainage (    <xref ref-type="bibr" rid="ref14">14</xref>
). In this study, these factors (sigmoid-type esophagus, the endoscopist experience, the use of a Triangular tip knife, and the use of an electrosurgical current different than spray coagulation) are associated with the occurrence of adverse events (    <xref ref-type="bibr" rid="ref14">14</xref>
).</p>
   <p id="b-14">Until now, whether published large multicenter study or case series with a large number, the reported adverse event rate rises 72.2%, but inexperienced hands, like Prof Inoue, this rate is only 3.2% (    <xref ref-type="bibr" rid="ref23">23</xref>
). Inoue published a paper including information on the first long-term results of a large (500 patients) case series in 2015. In this paper, he did not mention the use of prophylactic antibiotics. However, in 2016, again in a large study involving 200 patients, Ramchandani et al. reported adverse events occurred 10.64% and a prophylactic antibiotic using (5 days) was clearly stated. Again, in a study of POEM involvement of 44 children by the same group (Nabi et al), the adverse event rate was27.9%, while none of them were severe, and the use of prophylactic antibiotics was clearly stated without specifying a reason (    <xref ref-type="bibr" rid="ref8">8</xref>
). This study is the second paper investigating the necessity of antibiotic in POEM procedures. The first publication on this subject is the study of Bayeret alin2017. Inthe study, which included 124 patients (60 patients received gentamicin lavage and 64 patients did not), the levels of CRP and WBC were lower in the gentamicin lavage group [CRP: median 52.7 (IQR 34.9) vs. 69.5 (54.1); p=0.01; WBCs: median 10.9 (IQR 3.3) vs. 12.6 (3.9); p&lt;0.01], but no infectious adverse events was observed in either group.</p>
   <p id="b-15">Consequently, although gentamicin lavage has been shown to reduce systemic inflammatory response, it was emphasized that it has no role in preventing infection-related adverse events (    <xref ref-type="bibr" rid="ref17">17</xref>
). This observation was interpreted as clinically negligible. In our study, the number of patients is less than Bayer’s study (28 vs 124). Similarly, in our study, inflammatory markers (CRP and WBC) were lower in the group receiving systemic antibiotics and gentamicin, butthis wasinsignificant. We selected C-reactive protein and white blood cell count as a marker of inflammation to early recognition of any adverse event in postoperative 5 days. C-reactive protein and WBC are the most frequently used and followed markers in many inflammatory and severe septic conditions (    <xref ref-type="bibr" rid="ref6">6</xref>
). Haito-Chavez et al reported that the adverse event time occurred 57.1% in intraprocedural and 41% during the first 48 hours and only 1.9% revealed after this time (    <xref ref-type="bibr" rid="ref14">14</xref>
). In many large case series, esophageal leakage, which is the most potential problem that can cause fatal infection in POEM, usually manifests itself within the first 48 hours a serious clinic problem and fever (    <xref ref-type="bibr" rid="ref14">14</xref>
,    <xref ref-type="bibr" rid="ref22">22</xref>
). For this, we followed the first 5 days after the operation for the adverse event. To our best of knowledge, the postoperative course of CRP and WBC has not been studied as detailed information in the previous study. We observed that CRP commonly reached its highest level on the 3    <sup>rd</sup>
 day and then fell close to the normal level on the 5    <sup>th</sup>
 day. Moreover, the CRP level was slightly higher in the group of antibiotics negative, but this was not statistically significant. The major limitations of our study were the low number of patients and retrospective design. Since achalasia is a rare disease and this idea of antibiotic-free POEM is a new scientific concept, it is reasonable not to have a large number of patients in the study. However, apart from other studies, in addition to the classical achalasia POEM, we included different tunnel procedures such as Zenker’s and diverticulum POEM and gastric POEM. Moreover, again apart from other papers, we compared the course of the first post-operative 5-day of CRP and WBC (as operation day, day 1,3, and 5) in patients who received and did not receive antibiotics.</p>
  </sec>
  <sec id="sec-8">
   <title>Conclusion</title>
   <p id="b-16">To our findings, there is no longer a need to use prophylactic systemic antibiotics and genta micin tunnel lavage in the POEM procedure. Due to the rare incidence of achalasia and the fact that poem procedure can be performed in a limited number of centers around the world, these findings need to be confirmed in well-designed studies with a larger number of patients and prospective design.</p>
  </sec>
 </body>
 <back>
  <ref-list>
   <title>References</title>
   <ref id="ref1">
    <label>1</label>
    <mixed-citation publication-type="journal">Inoue H, Minami H, Kobayashi Y, Sato Y, Kaga M, Suzuki M, et al. Peroral endoscopic myotomy (POEM) for esophageal achalasia. Endoscopy. 2010;42(4):265-71</mixed-citation>
   </ref>
   <ref id="ref2">
    <label>2</label>
    <mixed-citation publication-type="journal">Inoue H, Tianle KM, Ikeda H, Hosoya T, Onimaru M, Yoshida A. Peroral endoscopic myotomy for esophageal achalasia: technique, indication, and outcomes. Thorac Surg Clin. 2011;21 (4):519-25</mixed-citation>
   </ref>
   <ref id="ref3">
    <label>3</label>
    <mixed-citation publication-type="journal">Yan J, Tan Y, Zhou B, Zhang S, Wang X, Liu D. Gastric per-oral endoscopic myotomy (G-POEM) is a promising treatment for refractory gastroparesis: a systematic review and meta-analysis. Rev Esp Enferm Dig. 2020;112(3):219-28</mixed-citation>
   </ref>
   <ref id="ref4">
    <label>4</label>
    <mixed-citation publication-type="journal">Sato H, Takeuchi M, Hashimoto S, Mizuno KI, Furukawa K, Sato A, et al. Esophageal diverticulum: New perspectives in the era of minimally invasive endoscopic treatment. World J Gastroenterol. 2019;25(12):1457-64 202 77 Systemic Antibiotic and Gentamicin Tunnel Lavage Tarık Akar</mixed-citation>
   </ref>
   <ref id="ref5">
    <label>5</label>
    <mixed-citation publication-type="journal">Bechara R, Onimaru M, Ikeda H, Inoue H. Per-oral endoscopic myotomy, 1000 cases later: pearls, pitfalls, and practical considerations. Gastrointest Endosc. 2016;84(2):330-8</mixed-citation>
   </ref>
   <ref id="ref6">
    <label>6</label>
    <mixed-citation publication-type="journal">Chai NL, Li HK, Linghu EQ, Li ZS, Zhang ST, Bao Y, et al. Consensus on the digestive endoscopic tunnel technique. World J Gastroenterol. 2019;25(7):744-76</mixed-citation>
   </ref>
   <ref id="ref7">
    <label>7</label>
    <mixed-citation publication-type="journal">Ramchandani M, Nageshwar Reddy D, Darisetty S, Kotla R, Chavan R, Kalpala R, et al. Peroral endoscopic myotomy for achalasia cardia: Treatment analysis and follow up of over 200 consecutive patients at a single center. Dig Endosc. 2016;28 (1):19-26</mixed-citation>
   </ref>
   <ref id="ref8">
    <label>8</label>
    <mixed-citation publication-type="journal">Nabi Z, Ramchandani M, Chavan R, Darisetty S, Kalapala R, Shava U, et al. Outcome of peroral endoscopic myotomy in children with achalasia. Surg Endosc. 2019;33(11):3656-64</mixed-citation>
   </ref>
   <ref id="ref9">
    <label>9</label>
    <mixed-citation publication-type="journal">Inoue H, Shiwaku H, Iwakiri K, Onimaru M, Kobayashi Y, Minami H, et al. Clinical practice guidelines for peroral endoscopic myotomy. Dig Endosc. 2018;30(5):563-79</mixed-citation>
   </ref>
   <ref id="ref10">
    <label>10</label>
    <mixed-citation publication-type="journal">Weusten BLAM, Barret M, Bredenoord AJ, Familiari P, Gonzalez JM, van Hooft JE, et al. Endoscopic management of gastrointestinal motility disorders - part 1: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy.</mixed-citation>
   </ref>
   <ref id="ref11">
    <label>11</label>
    <mixed-citation publication-type="journal">Podboy AJ, Hwang JH, Rivas H, Azagury D, Hawn M, Lau J, et al. Long-term outcomes of per-oral endoscopic myotomy compared to laparoscopic Heller myotomy for achalasia: a single-center experience. Surg Endosc. 2020</mixed-citation>
   </ref>
   <ref id="ref12">
    <label>12</label>
    <mixed-citation publication-type="journal">Crespin OM, Liu LWC, Parmar A, Jackson TD, Hamid J, Shlomovitz E, et al. Safety and efficacy of POEM for treatment of achalasia: a systematic review of the literature. Surg Endosc. 2017;31(5):2187-201</mixed-citation>
   </ref>
   <ref id="ref13">
    <label>13</label>
    <mixed-citation publication-type="journal">de Pascale S, Repici A, Puccetti F, Carlani E, Rosati R, Fumagalli U. Peroral endoscopic myotomy versus surgical myotomy for primary achalasia: single -center, retrospective analysis of 74 patients. Dis Esophagus. 2017;30(8):1-7</mixed-citation>
   </ref>
   <ref id="ref14">
    <label>14</label>
    <mixed-citation publication-type="journal">Haito-Chavez Y, Inoue H, Beard KW, Draganov PV, Ujiki M, Rahden BHA, et al. Comprehensive Analysis of Adverse Events Associated With Per Oral Endoscopic Myotomy in 1826 Patients: An International Multicenter Study. Am J Gastroenterol. 2017;112(8):1267-76</mixed-citation>
   </ref>
   <ref id="ref15">
    <label>15</label>
    <mixed-citation publication-type="journal">Chang WK, Srinivasa S, MacCormick AD, Hill AG. Gentamicin-collagen implants to reduce surgical site infection: systematic review and meta-analysis of randomized trials. Ann Surg. 2013;258(1):59-65</mixed-citation>
   </ref>
   <ref id="ref16">
    <label>16</label>
    <mixed-citation publication-type="journal">Tao J, Patel V, Mekaroonkamol P, Luo H, Li B, Guan Q, et al. Technical Aspects of Peroral Endoscopic Pyloromyotomy. Gastrointest Endosc Clin N Am. 2019;29(1):117-26</mixed-citation>
   </ref>
   <ref id="ref17">
    <label>17</label>
    <mixed-citation publication-type="journal">Bayer J, Vackova Z, Svecova H, Stirand P, Spicak J, Martinek J. Gentamicin submucosal lavage during peroral endoscopic myotomy (POEM): a retrospective analysis. Surg Endosc. 2018; 32(1):300-6</mixed-citation>
   </ref>
   <ref id="ref18">
    <label>18</label>
    <mixed-citation publication-type="journal">Becattini S, Taur Y, Pamer EG. Antibiotic-Induced Changes in the Intestinal Microbiota and Disease. Trends Mol Med. 2016; 22(6):458-78</mixed-citation>
   </ref>
   <ref id="ref19">
    <label>19</label>
    <mixed-citation publication-type="journal">Ichkhanian Y, Vosoughi K, Aghaie Meybodi M, Jacques J, Sethi A, Patel AA, et al. Comprehensive Analysis of Adverse Events Associated with Gastric Peroral Endoscopic Myotomy: An International Multicenter Study. Surg Endosc. 2020</mixed-citation>
   </ref>
   <ref id="ref20">
    <label>20</label>
    <mixed-citation publication-type="journal">Schimmer C, Gross J, Ramm E, Morfeld BC, Hoffmann G, Panholzer B, et al. Prevention of surgical site sternal infections in cardiac surgery: a two-centre prospective randomized controlled study. Eur J Cardiothorac Surg. 2017;51(1):67-72</mixed-citation>
   </ref>
   <ref id="ref21">
    <label>21</label>
    <mixed-citation publication-type="journal">Nabi Z, Reddy DN, Ramchandani M. Adverse events during and after per-oral endoscopic myotomy: prevention, diagnosis, and management. Gastrointest Endosc. 2018;87(1): 4-17</mixed-citation>
   </ref>
   <ref id="ref22">
    <label>22</label>
    <mixed-citation publication-type="journal">Zhang YQ, Yao LQ, Xu MD, Li QL, Chen WF, Hu JW, et al. Early diagnosis and management of esophageal leakage after peroral endoscopic myotomy for achalasia. Turk J Gastro enterol. 2016;27(2):97-102</mixed-citation>
   </ref>
   <ref id="ref23">
    <label>23</label>
    <mixed-citation publication-type="journal">Inoue H, Sato H, Ikeda H, Onimaru M, Sato C, Minami H, et al. Per-Oral Endoscopic Myotomy: A Series of 500 Patients. J Am Coll Surg. 2015;221(2):256-64</mixed-citation>
   </ref>
   <ref id="ref24">
    <label>24</label>
    <mixed-citation publication-type="journal">Patel K, Abbassi-Ghadi N, Markar S, Kumar S, Jethwa P, Zaninotto G. Peroral endoscopic myotomy for the treatment of esophageal achalasia: systematic review and pooled analysis. Dis Esophagus. 2016;29(7):807-19</mixed-citation>
   </ref>
   <ref id="ref25">
    <label>25</label>
    <mixed-citation publication-type="journal">Werner YB, Hakanson B, Martinek J, Repici A, von Rahden BHA, Bredenoord AJ, et al. Endoscopic or Surgical Myotomy in Patients with Idiopathic Achalasia. N Engl J Med. 2019;381 (23):2219-29</mixed-citation>
   </ref>
   <ref id="ref26">
    <label>26</label>
    <mixed-citation publication-type="journal">Zhai Y, Enquiang L, Huikai L, Xiaolin S, Lihua P. Is preoperative antibiotics necessary for infection preventing before peroral endoscopic myotomy. American Journal Gastroentrology. 2013;108(11):s587</mixed-citation>
   </ref>
   <ref id="ref27">
    <label>27</label>
    <mixed-citation publication-type="journal">Zhang XC, Li QL, Xu MD, Chen SY, Zhong YS, Zhang YQ, et al. Major perioperative adverse events of peroral endoscopic myotomy: a systematic 5-year analysis. Endoscopy. 2016;48 (11):967-78</mixed-citation>
   </ref>
  </ref-list>
 </back>
</article>
